Maze Therapeutics Inc. (MAZE)
NASDAQ: MAZE
· Real-Time Price · USD
29.26
0.76 (2.67%)
At close: Oct 15, 2025, 3:59 PM
29.26
0.00%
After-hours: Oct 15, 2025, 04:10 PM EDT
2.67% (1D)
| Bid | 27.75 |
| Market Cap | 1.28B |
| Revenue (ttm) | 2.5M |
| Net Income (ttm) | -120.8M |
| EPS (ttm) | -1.68 |
| PE Ratio (ttm) | -17.42 |
| Forward PE | -9.92 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 29.99 |
| Volume | 419,776 |
| Avg. Volume (20D) | 458,368 |
| Open | 28.31 |
| Previous Close | 28.50 |
| Day's Range | 28.31 - 29.43 |
| 52-Week Range | 6.71 - 29.66 |
| Beta | 4.58 |
| Ex-Dividend Date | n/a |
About MAZE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MAZE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MAZE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+54.81%
Maze Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
3 months ago
+24.26%
Maze Therapeutics shares are trading higher after Wedbush initiated coverage on the stock with an Outperform rating and announced a price target of $17.
